Vanguard Portfolio Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
FGP
Vanguard Portfolio Management's TNDM Position: Q2 2026 in Review
Vanguard Portfolio Management increased its Tandem Diabetes Care (TNDM) stake by 7.7% in Q2 2026, buying an estimated $5.35M and bringing the position to 4,299,667 shares worth $64.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1640.
Vanguard Portfolio Management first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $76.6M in Q1 2026. 271 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Vanguard Portfolio Management held 4,299,667 shares of Tandem Diabetes Care worth $64.9M as of Q2 2026.
- Vanguard Portfolio Management bought 306,334 Tandem Diabetes Care shares in Q2 2026, an estimated $5.35M.
- Tandem Diabetes Care made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1640 holding.
- Vanguard Portfolio Management first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
- Vanguard Portfolio Management's Tandem Diabetes Care position peaked at $76.6M in Q1 2026.
- 271 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.